Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

AACR Cancer Centers Alliance: Fostering Collaboration and Innovation to Advance Lifesaving Scientific Discoveries for Patients

Carlos L. Arteaga, John L. Cleveland, Margaret Foti, Ruben A. Mesa, Louis M. Weiner, Cheryl L. Willman, David A. Tuveson

Clin Cancer Res (2023) 29 (21): 4338–4340.

https://doi.org/10.1158/1078-0432.CCR-23-2625

Published: 01 November 2023

View articletitled, AACR Cancer Centers Alliance: Fostering Collaboration and Innovation to Advance Lifesaving Scientific Discoveries for Patients

Journal Articles

A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop

Clin Cancer Res (2021) 27 (20): 5472–5481.

https://doi.org/10.1158/1078-0432.CCR-21-1799

Published: 15 October 2021

View articletitled, A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop

Includes: Supplementary data

Journal Articles

A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer

Michael J. Pishvaian, Hongkun Wang, Aiwu Ruth He, Jimmy J. Hwang, Brandon G. Smaglo, Sunnie S. Kim, Benjamin A. Weinberg, Louis M. Weiner, John L. Marshall, Jonathan R. Brody

Clin Cancer Res (2020) 26 (19): 5092–5101.

https://doi.org/10.1158/1078-0432.CCR-20-1301

Published: 01 October 2020

View articletitled, A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer

Includes: Supplementary data

Journal Articles

Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3–MYC Interactions as a Target in Pancreatic Cancer

Clin Cancer Res (2016) 22 (24): 6153–6163.

https://doi.org/10.1158/1078-0432.CCR-16-0149

Published: 15 December 2016

View articletitled, Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3–MYC Interactions as a Target in Pancreatic Cancer

Includes: Supplementary data

Journal Articles

Abstract B07: Screening of patient-derived carcinoma cells and animal models identifies transcription as target in pancreatic cancer.

Vladimir Khazak, Natalia Skobeleva, Natalia Beglyarova, Egor Bobrov, Yan Zhou, Sandra A. Jablonski, Louis M. Weiner, Keren Paz, Igor Astsaturov

Clin Cancer Res (2016) 22 (16_Supplement): B07.

https://doi.org/10.1158/1557-3265.PDX16-B07

Published: 15 August 2016

View articletitled, Abstract B07: Screening of patient-derived carcinoma cells and animal models identifies transcription as target in pancreatic cancer.

Journal Articles

Abstract PL6-2: Antibody-initiated cancer immunotherapy

Louis M. Weiner, Yong Tang, Shangzi Wang, Rishi Surana, Wei Xu, Yu Zhou, James D. Marks, Erica Golemis

Clin Cancer Res (2010) 16 (7_Supplement): PL6-2.

https://doi.org/10.1158/1078-0432.TCME10-PL6-2

Published: 02 February 2016

View articletitled, Abstract PL6-2: Antibody-initiated cancer immunotherapy

Journal Articles

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

Martin A. Cheever, James P. Allison, Andrea S. Ferris, Olivera J. Finn, Benjamin M. Hastings, Toby T. Hecht, Ira Mellman, Sheila A. Prindiville, Jaye L. Viner, Louis M. Weiner, Lynn M. Matrisian

Clin Cancer Res (2009) 15 (17): 5323–5337.

https://doi.org/10.1158/1078-0432.CCR-09-0737

Published: 31 August 2009

View articletitled, The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

Includes: Supplementary data

Journal Articles

Translational Research Working Group Developmental Pathway for Immune Response Modifiers

Martin A. Cheever, Jeffrey Schlom, Louis M. Weiner, H. Kim Lyerly, Mary L. Disis, Addison Greenwood, Oren Grad, William G. Nelson, for the Translational Research Working Group

Clin Cancer Res (2008) 14 (18): 5692–5699.

https://doi.org/10.1158/1078-0432.CCR-08-1266

Published: 14 September 2008

View articletitled, Translational Research Working Group Developmental Pathway for Immune Response Modifiers

Journal Articles

Dose and Schedule Study of Panitumumab Monotherapy in Patients with Advanced Solid Malignancies

Louis M. Weiner, Arie S. Belldegrun, Jeffrey Crawford, Anthony W. Tolcher, Pamela Lockbaum, Rosalin H. Arends, Lynn Navale, Rafael G. Amado, Gisela Schwab, Robert A. Figlin

Clin Cancer Res (2008) 14 (2): 502–508.

https://doi.org/10.1158/1078-0432.CCR-07-1509

Published: 25 January 2008

View articletitled, Dose and Schedule Study of Panitumumab Monotherapy in Patients with Advanced Solid Malignancies

Journal Articles

Avidity-Mediated Enhancement of In vivo Tumor Targeting by Single-Chain Fv Dimers

Gregory P. Adams, Mei-Sheng Tai, John E. McCartney, James D. Marks, Walter F. Stafford, III, L.L. Houston, James S. Huston, Louis M. Weiner

Clin Cancer Res (2006) 12 (5): 1599–1605.

https://doi.org/10.1158/1078-0432.CCR-05-2217

Published: 06 March 2006

View articletitled, Avidity-Mediated Enhancement of In vivo Tumor Targeting by Single-Chain Fv Dimers

Journal Articles

Tumors and Their Microenvironments: Tilling the Soil : Commentary re: A. M. Scott et al ., A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer. Clin. Cancer Res., 9: 1639–1647, 2003.

Jonathan D. Cheng, Louis M. Weiner

Clin Cancer Res (2003) 9 (5): 1590–1595.

Published: 01 May 2003

View articletitled, Tumors and Their Microenvironments: Tilling the Soil : Commentary re: A. M. Scott et al ., A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer. Clin. Cancer Res., 9: 1639–1647, 2003.

Journal Articles

The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma

Margaret von Mehren, Philip Arlen, James Gulley, André Rogatko, Harry S. Cooper, Neal J. Meropol, R. Katharine Alpaugh, Monica Davey, Susan McLaughlin, Mary T. Beard, Kwong Y. Tsang, Jeffrey Schlom, Louis M. Weiner

Clin Cancer Res (2001) 7 (5): 1181–1191.

Published: 01 May 2001

View articletitled, The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma

Journal Articles

Phase I Pharmacokinetic Trial of Perillyl Alcohol (NSC 641066) in Patients with Refractory Solid Malignancies

Gary R. Hudes, Christine E. Szarka, Andrea Adams, Sulabha Ranganathan, Robert A. McCauley, Louis M. Weiner, Corey J. Langer, Samuel Litwin, Gwen Yeslow, Theresa Halberr, Mingxin Qian, James M. Gallo

Clin Cancer Res (2000) 6 (8): 3071–3080.

Published: 01 August 2000

View articletitled, Phase I Pharmacokinetic Trial of Perillyl Alcohol (NSC 641066) in Patients with Refractory Solid Malignancies

Journal Articles

Pilot Study of a Dual Gene Recombinant Avipox Vaccine Containing Both Carcinoembryonic Antigen (CEA) and B7.1 Transgenes in Patients with Recurrent CEA-expressing Adenocarcinomas

Margaret von Mehren, Philip Arlen, Kwong Y. Tsang, André Rogatko, Neal Meropol, Harry S. Cooper, Monica Davey, Susan McLaughlin, Jeffrey Schlom, Louis M. Weiner

Clin Cancer Res (2000) 6 (6): 2219–2228.

Published: 01 June 2000

View articletitled, Pilot Study of a Dual Gene Recombinant Avipox Vaccine Containing Both Carcinoembryonic Antigen (CEA) and B7.1 Transgenes in Patients with Recurrent CEA-expressing Adenocarcinomas

Journal Articles

Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody/Streptavidin in Patients with Metastatic Colon Cancer

Susan J. Knox, Michael L. Goris, Margaret Tempero, Paul L. Weiden, Louis Gentner, Hazel Breitz, Gregory P. Adams, Donald Axworthy, Sally Gaffigan, Kyle Bryan, Darrell R. Fisher, David Colcher, Ivan D. Horak, Louis M. Weiner

Clin Cancer Res (2000) 6 (2): 406–414.

Published: 01 February 2000

View articletitled, Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody/Streptavidin in Patients with Metastatic Colon Cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

AACR Cancer Centers Alliance: Fostering Collaboration and Innovation to Advance Lifesaving Scientific Discoveries for Patients

A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop

A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer

Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3–MYC Interactions as a Target in Pancreatic Cancer

Abstract B07: Screening of patient-derived carcinoma cells and animal models identifies transcription as target in pancreatic cancer.

Abstract PL6-2: Antibody-initiated cancer immunotherapy

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

Translational Research Working Group Developmental Pathway for Immune Response Modifiers

Dose and Schedule Study of Panitumumab Monotherapy in Patients with Advanced Solid Malignancies

Avidity-Mediated Enhancement of In vivo Tumor Targeting by Single-Chain Fv Dimers

Tumors and Their Microenvironments: Tilling the Soil : Commentary re: A. M. Scott et al ., A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer. Clin. Cancer Res., 9: 1639–1647, 2003.

The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma

Phase I Pharmacokinetic Trial of Perillyl Alcohol (NSC 641066) in Patients with Refractory Solid Malignancies

Pilot Study of a Dual Gene Recombinant Avipox Vaccine Containing Both Carcinoembryonic Antigen (CEA) and B7.1 Transgenes in Patients with Recurrent CEA-expressing Adenocarcinomas

Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody/Streptavidin in Patients with Metastatic Colon Cancer

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only